The Department of Health and Human Services announced new funding directed at controlling tick populations and preventing tickborne illnesses, including Lyme disease and the increasingly recognized alpha-gal syndrome, on Sept. 29.
Lyme disease is the most common vector-borne illness in the United States, with more than 476,000 estimated cases per year, according to the Centers for Disease Control and Prevention. Alpha-gal syndrome, a red meat allergy triggered by the bite of the lone star tick, has emerged as a growing public health concern with tens of thousands of new diagnoses annually.
The funding targets tick-endemic regions where disease burden is highest, HHS said. The initiative reflects growing federal attention to tickborne diseases, which have expanded geographically as tick habitats spread due to changing land use patterns and warming temperatures.
For Americans living in tick-endemic areas, primarily the Northeast, Upper Midwest, and mid-Atlantic regions, the federal investment addresses a direct public health risk. Lyme disease can cause debilitating long-term symptoms if untreated, including joint pain, neurological problems, and heart complications. Alpha-gal syndrome can trigger severe allergic reactions to red meat and other mammalian products.
The CDC has documented a significant expansion of tickborne disease cases over the past two decades, with the geographic range of disease-carrying ticks moving northward and into new regions. Climate and habitat changes have been cited as contributing factors.
Specific grant amounts and recipient organizations were not detailed in the HHS announcement. The department indicated the funding will support research into tick control methods and disease prevention strategies.
Tick control has historically received less federal research funding than prevention efforts for other vector-borne diseases, such as mosquito-borne illnesses. The new HHS investment signals an elevated priority for tickborne disease prevention in the department’s public health portfolio.